Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis and related disorders 2020-07, Vol.42, p.102201-102201
Hauptverfasser: Suwanwongse, Kulachanya, Shabarek, Nehad
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 102201
container_issue
container_start_page 102201
container_title Multiple sclerosis and related disorders
container_volume 42
creator Suwanwongse, Kulachanya
Shabarek, Nehad
description
doi_str_mv 10.1016/j.msard.2020.102201
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7227515</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32480327</sourcerecordid><originalsourceid>FETCH-LOGICAL-p785-9be18c37dcb0b592d987e8c21bd21b69f6d534ae64f6edb0f5def8629743df8f3</originalsourceid><addsrcrecordid>eNpVkOtKAzEQhYMoVmqfQJC8wNZcNtnsH0HrrVAoSPHvkk0mbcreSHYVfXpX1KIDhzmcYT6GQeiCkjklVF7t53XUwc4ZYV8JY4QeoTPGKE0IF_L44FM1QbMY92QsKWgq6SmacJYqwll2hp5vofHbBpt2CBFw6_Bi_bK8S2iOfYM1roeq910FOJoKQht9xJ3uPTQ97gPoHix-8_0Or02Ayn8MtS7P0YnTVYTZT5-izcP9ZvGUrNaPy8XNKukyJZK8BKoMz6wpSSlyZnOVgTKMlnaUzJ20gqcaZOok2JI4YcEpyfIs5dYpx6fo-hvbDWUN1ownBV0VXfC1Du9Fq33xf9L4XbFtX4uMsUxQMQIu_wIOm7_P4Z_hbmqa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Suwanwongse, Kulachanya ; Shabarek, Nehad</creator><creatorcontrib>Suwanwongse, Kulachanya ; Shabarek, Nehad</creatorcontrib><identifier>ISSN: 2211-0348</identifier><identifier>EISSN: 2211-0356</identifier><identifier>DOI: 10.1016/j.msard.2020.102201</identifier><identifier>PMID: 32480327</identifier><language>eng</language><publisher>Netherlands: Elsevier B. V</publisher><subject>Antibodies, Monoclonal, Humanized ; Betacoronavirus ; Coronavirus Infections ; Correspondence ; COVID-19 ; Humans ; Multiple Sclerosis ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2</subject><ispartof>Multiple sclerosis and related disorders, 2020-07, Vol.42, p.102201-102201</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32480327$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suwanwongse, Kulachanya</creatorcontrib><creatorcontrib>Shabarek, Nehad</creatorcontrib><title>Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab</title><title>Multiple sclerosis and related disorders</title><addtitle>Mult Scler Relat Disord</addtitle><subject>Antibodies, Monoclonal, Humanized</subject><subject>Betacoronavirus</subject><subject>Coronavirus Infections</subject><subject>Correspondence</subject><subject>COVID-19</subject><subject>Humans</subject><subject>Multiple Sclerosis</subject><subject>Pandemics</subject><subject>Pneumonia, Viral</subject><subject>SARS-CoV-2</subject><issn>2211-0348</issn><issn>2211-0356</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkOtKAzEQhYMoVmqfQJC8wNZcNtnsH0HrrVAoSPHvkk0mbcreSHYVfXpX1KIDhzmcYT6GQeiCkjklVF7t53XUwc4ZYV8JY4QeoTPGKE0IF_L44FM1QbMY92QsKWgq6SmacJYqwll2hp5vofHbBpt2CBFw6_Bi_bK8S2iOfYM1roeq910FOJoKQht9xJ3uPTQ97gPoHix-8_0Or02Ayn8MtS7P0YnTVYTZT5-izcP9ZvGUrNaPy8XNKukyJZK8BKoMz6wpSSlyZnOVgTKMlnaUzJ20gqcaZOok2JI4YcEpyfIs5dYpx6fo-hvbDWUN1ownBV0VXfC1Du9Fq33xf9L4XbFtX4uMsUxQMQIu_wIOm7_P4Z_hbmqa</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Suwanwongse, Kulachanya</creator><creator>Shabarek, Nehad</creator><general>Elsevier B. V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>5PM</scope></search><sort><creationdate>202007</creationdate><title>Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab</title><author>Suwanwongse, Kulachanya ; Shabarek, Nehad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p785-9be18c37dcb0b592d987e8c21bd21b69f6d534ae64f6edb0f5def8629743df8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibodies, Monoclonal, Humanized</topic><topic>Betacoronavirus</topic><topic>Coronavirus Infections</topic><topic>Correspondence</topic><topic>COVID-19</topic><topic>Humans</topic><topic>Multiple Sclerosis</topic><topic>Pandemics</topic><topic>Pneumonia, Viral</topic><topic>SARS-CoV-2</topic><toplevel>online_resources</toplevel><creatorcontrib>Suwanwongse, Kulachanya</creatorcontrib><creatorcontrib>Shabarek, Nehad</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Multiple sclerosis and related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suwanwongse, Kulachanya</au><au>Shabarek, Nehad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab</atitle><jtitle>Multiple sclerosis and related disorders</jtitle><addtitle>Mult Scler Relat Disord</addtitle><date>2020-07</date><risdate>2020</risdate><volume>42</volume><spage>102201</spage><epage>102201</epage><pages>102201-102201</pages><issn>2211-0348</issn><eissn>2211-0356</eissn><cop>Netherlands</cop><pub>Elsevier B. V</pub><pmid>32480327</pmid><doi>10.1016/j.msard.2020.102201</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2211-0348
ispartof Multiple sclerosis and related disorders, 2020-07, Vol.42, p.102201-102201
issn 2211-0348
2211-0356
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7227515
source MEDLINE; Alma/SFX Local Collection
subjects Antibodies, Monoclonal, Humanized
Betacoronavirus
Coronavirus Infections
Correspondence
COVID-19
Humans
Multiple Sclerosis
Pandemics
Pneumonia, Viral
SARS-CoV-2
title Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T15%3A38%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Benign%20course%20of%20COVID-19%20in%20a%20multiple%20sclerosis%20patient%20treated%20with%20Ocrelizumab&rft.jtitle=Multiple%20sclerosis%20and%20related%20disorders&rft.au=Suwanwongse,%20Kulachanya&rft.date=2020-07&rft.volume=42&rft.spage=102201&rft.epage=102201&rft.pages=102201-102201&rft.issn=2211-0348&rft.eissn=2211-0356&rft_id=info:doi/10.1016/j.msard.2020.102201&rft_dat=%3Cpubmed%3E32480327%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32480327&rfr_iscdi=true